Physician profile
Kirk T Ecklund
NPI 1154432904
$4,933.14
in general payments reported to CMS, 2019-2025
22 companies · $1,316 in 2025
The $1,316 reported for 2025 was more than what 80% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $397 · 2021: $399 · 2022: $555 · 2023: $840 · 2024: $890 · 2025: $1,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,709 · Education: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,708.51 |
| Education | $337.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,440.38 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Abbvie INC. | $1,253.60 | 2019-2025 | Skyrizi, Rinvoq |
| Lilly USA, LLC | $539.22 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Regeneron Healthcare Solutions, INC. | $326.02 | 2019-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $261.21 | 2022-2025 | Ilumya |
| Amgen INC. | $216.61 | 2020-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $206.16 | 2019-2025 | |
| Ucb, INC. | $185.65 | 2019-2025 | Bimzelx, Cimzia |
| Genzyme Corporation | $121.11 | 2019-2025 | |
| Leo Pharma INC. | $50.40 | 2022 | |
| Pfizer INC. | $46.30 | 2019-2022 | |
| Genentech USA, INC. | $45.44 | 2019-2022 | |
| Biofrontera INC. | $39.19 | 2019-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Incyte Corporation | $33.07 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $31.85 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $23.98 | 2023 | Idacio |
| Arcutis Biotherapeutics, INC. | $23.47 | 2023 | |
| Vyne Pharmaceuticals INC. | $21.58 | 2020 | |
| Celgene Corporation | $18.80 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.42 | 2024 | Sotyktu |
| Merck Sharp & Dohme LLC | $16.22 | 2019 | |
| Dermira, INC. | $14.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Ecklund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.